Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 222 Carcinoma, Non-Small-Cell Lung 219 Prostatic Neoplasms 156 Multiple Myeloma 142 Neoplasms 133 Colorectal Neoplasms 118 Leukemia, Myeloid, Acute 110 Lung Neoplasms 103 Neoplasm Metastasis 96 Squamous Cell Carcinoma of Head and Neck 91 Carcinoma, Hepatocellular 86 Lymphoma 81 Melanoma 78 Pancreatic Neoplasms 74 Triple Negative Breast Neoplasms 72 Ovarian Neoplasms 66 Sarcoma 65 Lymphoma, Large B-Cell, Diffuse 61 Carcinoma, Renal Cell 61 Brain Neoplasms 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Head and Neck Neoplasms 57 Recurrence 56 Lymphoma, Non-Hodgkin 55 Stomach Neoplasms 53 Leukemia, Lymphocytic, Chronic, B-Cell 52 Hematologic Neoplasms 52 Endometrial Neoplasms 50 Small Cell Lung Carcinoma 48 Urinary Bladder Neoplasms 46

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low Risk Prostate Cancer × 90 days × Clear all

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡